Call for Proposals: 12th ACT Research Symposium
Vascular contributions to cognitive impairment and dementia with a focus on sex differences
May 13-14, 2025
Seattle, WA
The call for abstracts and proposals from junior researchers is open now through January 15, 2025!
Please submit your proposal here.
The Adult Changes in Thought (ACT) study began in 1994 and has actively shared data with external collaborators to advance innovative projects in aging research. We are excited to host the 12th ACT Symposium to bring together researchers and other interested individuals in person to discuss research related to ACT and brain aging science.
For more information on the ACT study, please visit the ACT Study website.
ACT Symposium details: May 13-14, 2025, on the University of Washington campus in Seattle.
Eligibility: Any junior researcher (defined as assistant professor equivalent or below – such as lecturers, post-doctoral students, graduate students, or undergraduate students) who plans to attend the ACT Symposium is eligible.
The ACT Study recognizes that research aimed at understanding aging-associated disorders like dementia requires contributions from diverse perspectives. As such, the ACT Study encourages inclusive participation in our annual Research Symposium from scholars reflective of this important diversity.
Submission details:
Please use this form to submit either an abstract with research results or a proposal with a new study idea that uses ACT study or affiliated data (e.g., data from a different grant that developed out of ACT).
All submissions should include the following information:
- Name of presenter (must be a junior researcher as defined above)
- Presenter’s institutional affiliation
- Names of co-authors/collaborators
- Title of abstract or proposal
- In 400 words or less, your structured abstract or proposal:
- Abstracts should include structured sections such as a brief Background, Methods, Results, and Conclusions. Abstracts should include study results, not simply a statement implying that results are forthcoming.
- Proposals should include structured sections for Specific Aims, Background, and Proposed Methods. Proposals must leverage the ACT study data in some way.
Researchers may wish to use the ACT study Data Query Tool to obtain numbers and information about data availability for new proposals, but this is not required.
Additional information on collaboration and data resources can be found on the ACT website.
Selection process: Abstracts will be reviewed by a committee and rated on scientific merit, innovative use of the ACT study data, appropriate methods, and overall quality. Presenters will be notified by early February 2025.
If selected: You will be asked to present your abstract or proposal in person at the ACT Symposium on May 13 or 14, 2025. You will receive feedback on your work from a diverse group of faculty and partners with expertise in aging and dementia research. In addition, all researchers who submit an abstract or proposal will have the opportunity to schedule one-on-one time with ACT researchers to receive additional feedback and mentoring toward development of your study proposal.
Travel stipends are available for presenters traveling from outside the Seattle region. All are invited to attend regardless of whether you are participating as a presenter or not.
Additional information about the Symposium, including registration and hotel reservations will be posted on the ACT Website Symposium page.
For questions, please contact kpwhri.actsymposium@kp.org
Sent on behalf of the ACT Study 2025 Symposium Organizing Committee: Paul Crane, Nicole Gatto, Lynn Fleckenstein, KatieRose Johnson, Andrea LaCroix, Linda McEvoy, Kanichi Nakata, Alison Pak, Dori Rosenberg, and Lily Shapiro
Funding for this conference was made possible, in part by R13AG057087 from NIA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.